128 related articles for article (PubMed ID: 31864524)
1. Epigenetics and prostate cancer: defining the timing of DNA methyltransferase deregulation during prostate cancer progression.
Tzelepi V; Logotheti S; Efstathiou E; Troncoso P; Aparicio A; Sakellakis M; Hoang A; Perimenis P; Melachrinou M; Logothetis C; Zolota V
Pathology; 2020 Feb; 52(2):218-227. PubMed ID: 31864524
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive Analysis of DNA Methyltransferases Expression in Primary and Relapsed Ovarian Carcinoma.
Papakonstantinou E; Pappa I; Androutsopoulos G; Adonakis G; Maroulis I; Tzelepi V
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894317
[TBL] [Abstract][Full Text] [Related]
3. DNA methyltransferase and demethylase in human prostate cancer.
Patra SK; Patra A; Zhao H; Dahiya R
Mol Carcinog; 2002 Mar; 33(3):163-71. PubMed ID: 11870882
[TBL] [Abstract][Full Text] [Related]
4. Expression changes in EZH2, but not in BMI-1, SIRT1, DNMT1 or DNMT3B are associated with DNA methylation changes in prostate cancer.
Hoffmann MJ; Engers R; Florl AR; Otte AP; Muller M; Schulz WA
Cancer Biol Ther; 2007 Sep; 6(9):1403-12. PubMed ID: 18637271
[TBL] [Abstract][Full Text] [Related]
5. DNMT1 and DNMT3B regulate tumorigenicity of human prostate cancer cells by controlling RAD9 expression through targeted methylation.
Zhu A; Hopkins KM; Friedman RA; Bernstock JD; Broustas CG; Lieberman HB
Carcinogenesis; 2021 Feb; 42(2):220-231. PubMed ID: 32780107
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of DNA (Cytosine-5)-Methyltransferase 1 (DNMT1) And DNA (Cytosine-5)-Methyltransferase 3A (DNMT3A) Is Associated with Aggressive Behavior and Hypermethylation of Tumor Suppressor Genes in Human Pituitary Adenomas.
Ma HS; Wang EL; Xu WF; Yamada S; Yoshimoto K; Qian ZR; Shi L; Liu LL; Li XH
Med Sci Monit; 2018 Jul; 24():4841-4850. PubMed ID: 30002361
[TBL] [Abstract][Full Text] [Related]
7. Stage-specific alterations of DNA methyltransferase expression, DNA hypermethylation, and DNA hypomethylation during prostate cancer progression in the transgenic adenocarcinoma of mouse prostate model.
Morey Kinney SR; Smiraglia DJ; James SR; Moser MT; Foster BA; Karpf AR
Mol Cancer Res; 2008 Aug; 6(8):1365-74. PubMed ID: 18667590
[TBL] [Abstract][Full Text] [Related]
8. Endogenous assays of DNA methyltransferases: Evidence for differential activities of DNMT1, DNMT2, and DNMT3 in mammalian cells in vivo.
Liu K; Wang YF; Cantemir C; Muller MT
Mol Cell Biol; 2003 Apr; 23(8):2709-19. PubMed ID: 12665573
[TBL] [Abstract][Full Text] [Related]
9. DNA Methyltransferases in Mammalian Oocytes.
Uysal F; Ozturk S
Results Probl Cell Differ; 2017; 63():211-222. PubMed ID: 28779320
[TBL] [Abstract][Full Text] [Related]
10. Molecular enzymology of mammalian DNA methyltransferases.
Jeltsch A
Curr Top Microbiol Immunol; 2006; 301():203-25. PubMed ID: 16570849
[TBL] [Abstract][Full Text] [Related]
11. Dynamic expression of DNA methyltransferases (DNMTs) in oocytes and early embryos.
Uysal F; Akkoyunlu G; Ozturk S
Biochimie; 2015 Sep; 116():103-13. PubMed ID: 26143007
[TBL] [Abstract][Full Text] [Related]
12. DNA methyltransferase 3-like affects promoter methylation of thymine DNA glycosylase independently of DNMT1 and DNMT3B in cancer cells.
Kim H; Park J; Jung Y; Song SH; Han SW; Oh DY; Im SA; Bang YJ; Kim TY
Int J Oncol; 2010 Jun; 36(6):1563-72. PubMed ID: 20428781
[TBL] [Abstract][Full Text] [Related]
13. [DNA methyltransferases: classification, functions and research progress].
Wang ZG; Wu JX
Yi Chuan; 2009 Sep; 31(9):903-12. PubMed ID: 19819843
[TBL] [Abstract][Full Text] [Related]
14. Opposing roles of Dnmt1 in early- and late-stage murine prostate cancer.
Kinney SR; Moser MT; Pascual M; Greally JM; Foster BA; Karpf AR
Mol Cell Biol; 2010 Sep; 30(17):4159-74. PubMed ID: 20584988
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth.
Cho CC; Lin CJ; Huang HH; Yang WZ; Fei CY; Lin HY; Lee MS; Yuan HS
ACS Chem Biol; 2023 Jun; 18(6):1335-1350. PubMed ID: 37188336
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation by DNMT1 and DNMT3b methyltransferases is driven by the MUC1-C oncoprotein in human carcinoma cells.
Rajabi H; Tagde A; Alam M; Bouillez A; Pitroda S; Suzuki Y; Kufe D
Oncogene; 2016 Dec; 35(50):6439-6445. PubMed ID: 27212035
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of the DNMTs mRNA expression and genetic polymorphisms on the clinical outcome in oral cancer patients.
Supic G; Kozomara R; Zeljic K; Jovic N; Magic Z
Clin Oral Investig; 2017 Jan; 21(1):173-182. PubMed ID: 26966018
[TBL] [Abstract][Full Text] [Related]
18. Opposite alterations of DNA methyltransferase gene expression in endometrioid and serous endometrial cancers.
Xiong Y; Dowdy SC; Xue A; Shujuan J; Eberhardt NL; Podratz KC; Jiang SW
Gynecol Oncol; 2005 Mar; 96(3):601-9. PubMed ID: 15721400
[TBL] [Abstract][Full Text] [Related]
19. The Roles of Human DNA Methyltransferases and Their Isoforms in Shaping the Epigenome.
Gujar H; Weisenberger DJ; Liang G
Genes (Basel); 2019 Feb; 10(2):. PubMed ID: 30813436
[TBL] [Abstract][Full Text] [Related]
20. Increased levels of DNA methyltransferases are associated with the tumorigenic capacity of prostate cancer cells.
Gravina GL; Ranieri G; Muzi P; Marampon F; Mancini A; Di Pasquale B; Di Clemente L; Dolo V; D'Alessandro AM; Festuccia C
Oncol Rep; 2013 Mar; 29(3):1189-95. PubMed ID: 23254386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
